TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Xxlofoten AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
39,576
|
27,925
|
23,982 |
| Financial expenses |
464
|
426
|
317 |
| Earnings before taxes |
4,438
|
5,092
|
4,615 |
| Total assets |
26,745
|
21,186
|
25,979 |
| Current assets |
17,868
|
10,894
|
12,875 |
| Current liabilities |
15,500
|
7,678
|
1,751 |
| Equity capital |
5,156
|
6,504
|
16,610 |
| - share capital |
3,709
|
3,709
|
3,709 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
19.3%
|
30.7%
|
63.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
11.2%
|
18.2%
|
19.2% |
| Return on assets (ROA) |
18.3%
|
26.0%
|
19.0% |
| Current ratio |
115.3%
|
141.9%
|
735.3% |
| Return on equity (ROE) |
86.1%
|
78.3%
|
27.8% |
| Change turnover |
11,651
|
3,943
|
8,350 |
| Change turnover % |
42%
|
16%
|
53% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.